Leerink Partnrs Weighs in on ACHC Q2 Earnings

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) – Stock analysts at Leerink Partnrs issued their Q2 2025 earnings per share (EPS) estimates for Acadia Healthcare in a note issued to investors on Wednesday, May 14th. Leerink Partnrs analyst W. Mayo forecasts that the company will post earnings of $0.61 per share for the quarter. The consensus estimate for Acadia Healthcare’s current full-year earnings is $3.38 per share. Leerink Partnrs also issued estimates for Acadia Healthcare’s Q3 2025 earnings at $0.78 EPS, Q4 2025 earnings at $0.79 EPS, Q1 2026 earnings at $0.49 EPS, Q2 2026 earnings at $0.72 EPS, Q3 2026 earnings at $0.87 EPS, FY2026 earnings at $2.91 EPS and FY2027 earnings at $3.32 EPS.

Acadia Healthcare (NASDAQ:ACHC) last issued its earnings results on Monday, May 12th. The company reported $0.40 EPS for the quarter, topping the consensus estimate of $0.35 by $0.05. The firm had revenue of $770.51 million during the quarter, compared to the consensus estimate of $769.90 million. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The business’s quarterly revenue was up .3% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.84 earnings per share.

Other analysts have also recently issued reports about the company. Bank of America reduced their price target on Acadia Healthcare from $50.00 to $44.50 and set a “buy” rating on the stock in a report on Friday, February 28th. Mizuho cut their price target on Acadia Healthcare from $37.00 to $32.00 and set a “neutral” rating on the stock in a report on Wednesday, May 14th. Guggenheim assumed coverage on Acadia Healthcare in a research report on Wednesday, April 9th. They set a “buy” rating and a $36.00 target price on the stock. Royal Bank of Canada lowered their target price on Acadia Healthcare from $64.00 to $43.00 and set an “outperform” rating on the stock in a research report on Monday, March 3rd. Finally, KeyCorp lowered their price target on Acadia Healthcare from $65.00 to $55.00 and set an “overweight” rating for the company in a research report on Wednesday, May 14th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and six have assigned a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $47.94.

Acadia Healthcare Stock Performance

NASDAQ:ACHC opened at $25.20 on Monday. The stock has a market cap of $2.32 billion, a P/E ratio of 8.26, a price-to-earnings-growth ratio of 1.46 and a beta of 1.01. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60. The stock’s 50-day moving average is $26.06 and its 200-day moving average is $35.30. Acadia Healthcare has a 1-year low of $20.36 and a 1-year high of $82.41.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the company. Treasurer of the State of North Carolina boosted its stake in Acadia Healthcare by 0.6% in the 4th quarter. Treasurer of the State of North Carolina now owns 40,005 shares of the company’s stock worth $1,586,000 after purchasing an additional 250 shares during the period. Nisa Investment Advisors LLC grew its position in Acadia Healthcare by 40.7% during the fourth quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company’s stock worth $41,000 after buying an additional 301 shares in the last quarter. Coldstream Capital Management Inc. grew its position in Acadia Healthcare by 4.9% during the fourth quarter. Coldstream Capital Management Inc. now owns 6,470 shares of the company’s stock worth $257,000 after buying an additional 303 shares in the last quarter. Covestor Ltd boosted its position in shares of Acadia Healthcare by 27.2% during the 4th quarter. Covestor Ltd now owns 1,450 shares of the company’s stock valued at $58,000 after acquiring an additional 310 shares during the last quarter. Finally, Pacer Advisors Inc. boosted its position in shares of Acadia Healthcare by 2.4% during the 4th quarter. Pacer Advisors Inc. now owns 13,847 shares of the company’s stock valued at $549,000 after acquiring an additional 325 shares during the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.